VOYAGER THERAPEUTICS INC (VYGR) — insider trading
Health Care · NASDAQ
VOYAGER THERAPEUTICS INC (VYGR) has 11 reported SEC Form 4 insider transactions in our data, including 1 open-market sale among the most recent 11 (latest 2026-06-09).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-09 | PIERCE GLENN | Director | Grant / award / vesting (derivative) | 30,000 | — | $0 | Form 4 |
| 2026-06-09 | Colon Grace | Director | Grant / award / vesting (derivative) | 30,000 | — | $0 | Form 4 |
| 2026-06-09 | GERAGHTY JAMES A | Director | Grant / award / vesting (derivative) | 30,000 | — | $0 | Form 4 |
| 2026-06-09 | Onyia Jude | Director | Grant / award / vesting (derivative) | 30,000 | — | $0 | Form 4 |
| 2026-06-09 | Higgins Michael J | Director | Grant / award / vesting (derivative) | 30,000 | — | $0 | Form 4 |
| 2026-06-09 | Vitale Nancy | Director | Grant / award / vesting (derivative) | 30,000 | — | $0 | Form 4 |
| 2026-06-09 | Hyman Steven | Director | Grant / award / vesting (derivative) | 30,000 | — | $0 | Form 4 |
| 2026-06-09 | MACKEY CATHERINE J | Director | Grant / award / vesting (derivative) | 30,000 | — | $0 | Form 4 |
| 2026-06-09 | SCANGOS GEORGE A | Director | Grant / award / vesting (derivative) | 30,000 | — | $0 | Form 4 |
| 2026-04-02 | Sandrock Alfred | Director, Officer (President and CEO) | Open-market sale | 11,511 | $3.87 | $44.5K | Form 4 |
| 2026-04-01 | Shiferman Gregory L. | Officer (SVP and General Counsel) | Grant / award / vesting | 50,000 | — | $0 | Form 4 |
Ask the chat about VYGR's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: VOYAGER THERAPEUTICS INC (VYGR).
Last updated 2026-06-09 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.